Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001854270-23-000012
Filing Date
2023-01-27
Accepted
2023-01-27 07:36:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 a20230127prospectussupplem.htm 424B3 38351
2 senti_logoxfilings.jpg GRAPHIC 3916
  Complete submission text file 0001854270-23-000012.txt   45095
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267390 | Film No.: 23559678
SIC: 2836 Biological Products, (No Diagnostic Substances)